Skip to main content

Find Clinical Trials

Home
Conditions
Rectal Cancer Patients

Clinical trial condition

Rectal Cancer Patients

Explore clinical trials studying Rectal Cancer Patients. Study availability and eligibility vary by location and protocol.

31 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Rectal Cancer Patients trial results

Recruiting

Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC

NCT07291401

Conditions: Rectal Cancer Patients
Locations: Zhongnan Hospital of Wuhan University Wuhan, Hubei, China

View Trial Details

Recruiting

Single-port Versus Multi-port Robotic Surgery for Rectal Cancer

NCT06824688

Conditions: Rectal Cancer Patients, Robotic Surgical Procedures
Locations: Huichao Zheng Chongqing, China

View Trial Details

Recruiting

Oncolytic Virotherapy to Enhance PReoperative IMmunotherapy Efficacy in Patients With Proficient Mismatch Repair (pMMR) Rectal Cancer

NCT07687875

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Copenhagen University Hospital - Bispebjerg and Frederiksberg Copenhagen, Captial Region, Denmark

View Trial Details

Recruiting

Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery

NCT03051464

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations: UT Southwestern Medical Center Dallas, Texas, United States

Le Centre Hospitalier de l'Université de Montreal Montreal, Quebec, Canada

Jewish General Hospital Montreal, Quebec, Canada

Centre hospitalier universitaire de Québec Québec, Quebec, Canada

View Trial Details

Recruiting

Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision

NCT07651553

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: the sixth affiliated hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression

NCT07176182

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations: The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Evaluation of Gynecological and Sexual Sequelae

NCT07389863

Conditions: Rectal Cancer Patients
Locations: Service de Chirurgie Digestive Rouen, France

View Trial Details

Recruiting

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

NCT06850090

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Recruiting

Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.

NCT06911684

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651 Guangzhou, Guangdong, China

View Trial Details

Recruiting

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

NCT06647680

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations: The affiliated hospital of Qingdao university Qingdao, Shandong, China

View Trial Details